XML 58 R47.htm IDEA: XBRL DOCUMENT v3.21.2
NOTE 8 – STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Nov. 13, 2020
Jul. 09, 2020
Aug. 31, 2020
Jul. 31, 2020
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Subsidiary, Sale of Stock [Line Items]                    
Reverse stock split, description         effected a 5:1 reverse stock split          
Unrecognized compensation expense             $ 1,814,191   $ 1,814,191  
Share-based compensation expense                 100,896 $ 0
Warrant liability             435,577   435,577  
Gain (loss) on the change in fair value of warrant liability             10,948   300,452  
Stock based compensation             $ 465,600 $ 101,607 $ 676,341 $ 101,607
August Offering [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of common stock issued during the period     1,000,000              
Public offering price     $ 5.00              
Gross proceeds from issuance     $ 5,750,000              
Underwriting fees     517,500              
Write-off of capitalized IPO Costs     341,145              
Net proceeds from issuance     $ 4,891,355              
Shares issued to Carmel, Milazzo & Feil LLP (in shares)     167,794              
November Offering [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of common stock issued during the period 1,401,905                  
Public offering price $ 5.25                  
Gross proceeds from issuance $ 7,360,000                  
Underwriting fees 625,600                  
Write-off of capitalized IPO Costs 316,246                  
Net proceeds from issuance $ 6,418,155                  
Options [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Unrecognized share-based payment recognized period                 3 years 2 months 12 days  
Restricted Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Restricted stock granted       230,083            
Restricted stock vested                 85,055  
Share Price             $ 5   $ 5  
Restricted Stock 1 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Restricted stock granted   62,500                
Restricted stock vested             0   0  
Share Price             $ 5   $ 5  
Restricted Stock 2 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Restricted stock granted   40,000                
Restricted stock vested                 5,000  
Stock based compensation             $ 12,500   $ 25,000  
Restricted Stock 3 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share Price             $ 4.57   $ 4.57  
Stock based compensation             $ 71,406   $ 142,813  
Incentive Plan 2020 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of common stock issued during the period           600,000        
Number of shares available for grant           330,250        
Additional option granted           309,564